A single lysis solution for the analysis of tissue samples by different proteomic technologies

Molecular Oncology - Tập 2 - Trang 368-379 - 2008
Pavel Gromov1,2, Julio E. Celis1,2, Irina Gromova1,2, Fritz Rank2,3, Vera Timmermans-Wielenga2,3, José M.A. Moreira1,2
1Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
2Danish Centre for Translational Breast Cancer Research, Copenhagen, Denmark
3Department of Pathology, the Centre of Diagnostic Investigations, Rigshospitalet, Denmark

Tóm tắt

Cancer, being a major healthcare concern worldwide, is one of the main targets for the application of emerging proteomic technologies and these tools promise to revolutionize the way cancer will be diagnosed and treated in the near future. Today, as a result of the unprecedented advances that have taken place in molecular biology, cell biology and genomics there is a pressing need to accelerate the translation of basic discoveries into clinical applications. This need, compounded by mounting evidence that cellular model systems are unable to fully recapitulate all biological aspects of human dissease, is driving scientists to increasingly use clinically relevant samples for biomarker and target discovery. Tissues are heterogeneous and as a result optimization of sample preparation is critical for generating accurate, representative, and highly reproducible quantitative data. Although a large number of protocols for preparation of tissue lysates has been published, so far no single recipe is able to provide a “one‐size fits all” solubilization procedure that can be used to analyse the same lysate using different proteomics technologies. Here we present evidence showing that cell lysis buffer 1 (CLB1), a lysis solution commercialized by Zeptosens [a division of Bayer (Schweiz) AG], provides excellent sample solubilization and very high 2D PAGE protein resolution both when using carrier ampholytes and immobilized pH gradient strips. Moreover, this buffer can also be used for array‐based proteomics (reverse‐phase lysate arrays or direct antibody arrays), allowing the direct comparison of qualitative and quantitative data yielded by these technologies when applied to the same samples. The usefulness of the CLB1 solution for gel‐based proteomics was further established by 2D PAGE analysis of a number of technically demanding specimens such as breast carcinoma core needle biopsies and problematic tissues such as brain cortex, cerebellum, skeletal muscle, kidney cortex and tongue. This solution when combined with a specific sample preparation technique – cryostat sectioning of frozen specimens – simplifies tissue sample preparation and solves most of the difficulties associated with the integration of data generated by different proteomic technologies.

Tài liệu tham khảo

10.1038/nature01511 10.1016/j.molonc.2007.01.003 10.1038/35077225 10.1016/j.jchromb.2006.10.040 10.1038/nprot.2006.104 10.1016/S1535-6108(02)00242-8 10.1002/(SICI)1522-2683(19990201)20:2<355::AID-ELPS355>3.0.CO;2-N 10.1074/mcp.R300007-MCP200 10.1074/mcp.M400009-MCP200 10.1111/j.1432-1033.2004.04418.x 10.1074/mcp.M500030-MCP200 Celis J.E., 2006, A Cell Biology. Laboratory Handbook, 165 10.1016/B978-012164730-8/50064-2 10.1016/j.molonc.2007.02.005 10.1016/j.molonc.2007.09.004 Celis J.E., 2008, 15-PGDH expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinomae. Mol. Cell, Proteomics 10.1016/j.molonc.2007.05.001 10.1038/nature06525 Dominguez D.C., 2007, Proteomics: clinical applications, Clin. Lab. Sci., 20, 245 10.1373/clinchem.2004.033225 10.1016/j.molonc.2007.06.001 10.1101/sqb.2005.70.022 10.1074/mcp.M400075-MCP200 10.1002/pmic.200401031 Gromova I., 2006, Protein detection in gels by silver staining: a procedure compatible with mass spectrometry, Cell Biology. A Laboratory Handbook, 219 Haab B.B. Dunham M.J. Brown P.O. 2001. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions Genome Biol. 2 RESEARCH0004. 10.2214/ajr.171.1.9648764 10.1016/j.copbio.2007.11.006 10.1073/pnas.77.3.1311 10.2144/000112823 10.1016/j.molonc.2008.05.003 10.1021/ac0709955 10.1016/j.molonc.2007.02.004 Koomen J.M., 2008, Proteomic contributions to personalized cancer care. Mol. Cell, Proteomics Kruse U., 2008, Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. Mol. Cell, Proteomics Li J. Gromov P. Gromova I. Moreira J.M. Timmermans-Wielenga V. Rank F. Wang K. Li S. Li H. Wiuf C. Yang H. Zhang X. Bolund L. Celis J.E. 2008. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics in press. 10.1016/S1535-6108(03)00086-2 10.1016/j.molonc.2007.08.004 McDonald W.H., 2003, Shotgun proteomics: integrating technologies to answer biological questions, Curr. Opin. Mol. Ther, 5, 302 10.1016/S0021-9258(19)41496-8 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.0.CO;2-A Rabilloud T., 2007, Detergents and chaotropes for protein solubilization before two-dimensional electrophoresis, Methods Mol. Biol., 355, 111 10.1002/cncr.22686 10.1016/j.molonc.2008.07.004 10.1016/S0065-2423(07)44004-5 10.1038/nbt1235 10.1021/ac950914h 10.1016/j.cbpa.2008.02.010 10.1016/j.molonc.2007.03.005 10.1007/978-1-60327-064-9_3 10.1002/pmic.200500078 10.1089/omi.2006.10.411 10.1002/pmic.200300591
Thông tin
Thông tin xuất bản

Molecular Oncology

Tập 2

368-379

Thông tin tác giả